CD8A and neoplasm: There has been a general consensus that tumor-infiltrating CD4+ and CD8+ effector T lymphocytes are mediators of the response to ICB and that these cells are primed through tumor antigen presentation by dendritic cells, while natural killer cells play important roles in the immune surveillance of tumors (10).